These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3902910)

  • 1. Fluctuations in crevicular and salivary anti-A. viscosus antibody levels in response to treatment of gingivitis.
    Tynelius-Bratthall G; Ellen RP
    J Clin Periodontol; 1985 Oct; 12(9):762-73. PubMed ID: 3902910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crevicular and salivary fibronectin before and after gingivitis treatment.
    Tynelius-Bratthall G
    J Clin Periodontol; 1988 May; 15(5):283-7. PubMed ID: 3292593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in salivary antibodies to commensal oral and gut biota.
    Percival RS; Marsh PD; Challacombe SJ
    Oral Microbiol Immunol; 1997 Feb; 12(1):57-63. PubMed ID: 9151645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parotid salivary S-IgA antibodies during experimental gingivitis in smokers and non-smokers.
    Lie MA; Myint MM; Schenck K; Timmerman MF; van der Velden U; van der Weijden GA; Loos BG
    J Periodontal Res; 2002 Apr; 37(2):86-92. PubMed ID: 12009188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotypic antibody response to plaque anaerobes in periodontal disease.
    Plombas M; Gobert B; De March AK; Sarda MN; Sixou M; Béné MC; Miller N; Faure GC
    J Periodontol; 2002 Dec; 73(12):1507-11. PubMed ID: 12546101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of salivary IgA antibodies reactive with bacteria from dental plaque are associated with susceptibility to experimental gingivitis.
    Schenck K; Poppelsdorf D; Denis C; Tollefsen T
    J Clin Periodontol; 1993 Jul; 20(6):411-7. PubMed ID: 8394390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans-associated periodontal disease.
    Genco RJ; Zambon JJ; Murray PA
    J Periodontol; 1985 Nov; 56(11 Suppl):41-50. PubMed ID: 3908639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans.
    Seemann R; Hägewald SJ; Sztankay V; Drews J; Bizhang M; Kage A
    Clin Oral Investig; 2004 Dec; 8(4):233-7. PubMed ID: 15316859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinomyces viscosus and Actinomyces naeslundii agglutinins in human saliva.
    Ellen RP; Bratthall D; Borgström M; Howley TP
    Scand J Dent Res; 1983 Aug; 91(4):263-73. PubMed ID: 6579605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity in root caries in an elderly population. 1.
    Butler JE; Spradling JE; Peterman JH; Joshi KS; Satam M; Challacombe SJ
    Oral Microbiol Immunol; 1990 Apr; 5(2):98-107. PubMed ID: 2087357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between gingival fluid and mixed and parotid salivary IgA.
    Demetriou N; Drikos G; Bambionitakis A
    J Periodontol; 1978 Feb; 49(2):64-6. PubMed ID: 353246
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin.
    Engström PE; George M; Larsson P; Lally ET; Taichman NS; Norhagen G
    Oral Microbiol Immunol; 1999 Apr; 14(2):104-8. PubMed ID: 10219169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status.
    Mooney J; Kinane DF
    Oral Microbiol Immunol; 1997 Apr; 12(2):112-6. PubMed ID: 9227135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary immunoglobulins in cancer patients with chemotherapy-related oral mucosa damage.
    Janković L; Jelić S; Filipović-Ljesković I; Ristović Z
    Eur J Cancer B Oral Oncol; 1995 May; 31B(3):160-5. PubMed ID: 7549754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and levels of oral and systemic antibodies to Actinobacillus actinomycetemcomitans.
    Engström PE; Larsson A; Norhagen G; Smith CI; Sällberg M; Helgeland K; Hammarstöm L
    J Clin Periodontol; 1993 Nov; 20(10):746-51. PubMed ID: 8276986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of antibodies and opsonic activity in human crevicular fluid in relation to periodontal disease.
    Challacombe SJ; Wilton JM
    J Periodontal Res; 1984 Nov; 19(6):604-8. PubMed ID: 6241236
    [No Abstract]   [Full Text] [Related]  

  • 17. Level of Interleukin-35 in Gingival Crevicular Fluid, Saliva, and Plasma in Periodontal Disease and Health.
    Köseoğlu S; Sağlam M; Pekbağrıyanık T; Savran L; Sütçü R
    J Periodontol; 2015 Aug; 86(8):964-71. PubMed ID: 25786564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary IgG, a parameter of periodontal disease activity? High responders to Actinobacillus actinomycetemcomitans Y4 in juvenile and adult periodontitis.
    Sandholm L; Tolo K; Olsen I
    J Clin Periodontol; 1987 May; 14(5):289-94. PubMed ID: 3475296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local immune responses to periodontopathic bacteria. I. Relationship of the IgG titers in serum and gingival crevicular fluid].
    Horibe M
    Kokubyo Gakkai Zasshi; 1988 Sep; 55(3):483-91. PubMed ID: 3060555
    [No Abstract]   [Full Text] [Related]  

  • 20. [The nonspecific resistance of the oral cavity in adolescents].
    Krechina EK; Khazanova VV; Zemskaia EA
    Stomatologiia (Mosk); 1991; (2):29-31. PubMed ID: 1853374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.